Haemonetics Announces CFO William P. Burke's Retirement for June 2022
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Haemonetics (HAE) PT Lowered to $80 at Jefferies
November 10, 2021 8:10 AM ESTJefferies analyst Anthony Petrone lowered the price target on Haemonetics (NYSE: HAE) to $80.00 (from $85.00) while maintaining a Buy rating.
The analyst commented, "Key updates from the call: 1) US plasma volumes improved to +20% (+14% last Q), 2) Nov volumes flat at +20% (high-end of revised... More
